First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency
Clinical trial NCT07136922 · RECRUITING
Trial details
- NCT number
- NCT07136922
- Sponsor
- Calla Lily Clinical Care Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2026-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.